Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

CUSIP: 761330109

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
104,661,494
Total 13F shares
49,472,050
Share change
-1,072,002
Total reported value
$1,246,067,821
Put/Call ratio
149%
Price per share
$25.14
Number of holders
151
Value change
-$26,647,818
Number of buys
82
Number of sells
49

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
4.2%
4,439,200
$108,406,000 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
3.8%
4,027,774
$98,358,000 30 Jun 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.6%
3,756,798
$91,741,000 30 Jun 2020
13F
ArrowMark Colorado Holdings LLC
13F
Company
3.4%
3,579,711
$87,417,000 30 Jun 2020
13F
FRANKLIN RESOURCES INC
13F
Company
3.3%
3,466,888
$83,309,000 30 Jun 2020
13F
Essex Woodlands Management, Inc.
13F
Company
3.2%
3,342,047
$81,613,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
2.8%
2,894,383
$70,681,000 30 Jun 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
2.7%
2,792,810
$68,200,000 30 Jun 2020
13F
Capital World Investors
13F
Company
2%
2,130,000
$52,015,000 30 Jun 2020
13F
JENNISON ASSOCIATES LLC
13F
Company
2%
2,126,541
$51,930,000 30 Jun 2020
13F
Palo Alto Investors LP
13F
Company
1.6%
1,704,372
$41,621,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
1.3%
1,350,080
$32,969,000 30 Jun 2020
13F
Polar Capital LLP
13F
Company
1.2%
1,283,213
$31,336,000 30 Jun 2020
13F
Capital International Investors
13F
Company
1.1%
1,161,900
$28,374,000 30 Jun 2020
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.99%
1,033,279
$25,233,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.76%
797,452
$19,473,000 30 Jun 2020
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.72%
749,430
$18,301,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.71%
738,465
$18,033,000 30 Jun 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.61%
639,861
$15,627,000 30 Jun 2020
13F
NovaQuest Capital Management, L.L.C.
13F
Company
0.57%
598,985
$14,627,000 30 Jun 2020
13F
BAMCO INC /NY/
13F
Company
0.56%
581,732
$14,206,000 30 Jun 2020
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.54%
564,758
$13,792,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.54%
560,875
$13,696,000 30 Jun 2020
13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.
13F
Company
0.46%
483,576
$11,809,000 30 Jun 2020
13F
Fosun International Ltd
13F
Company
0.42%
443,841
$10,839,000 30 Jun 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.38%
400,856
$9,789,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.32%
336,020
$8,206,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
0.27%
279,371
$6,822,000 30 Jun 2020
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.24%
253,390
$6,188,000 30 Jun 2020
13F
OSTERWEIS CAPITAL MANAGEMENT INC
13F
Company
0.22%
229,010
$5,592,000 30 Jun 2020
13F
Rhenman & Partners Asset Management AB
13F
Company
0.21%
220,000
$5,372,000 30 Jun 2020
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.14%
147,599
$3,605,000 30 Jun 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.13%
134,567
$3,285,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.12%
127,282
$3,108,000 30 Jun 2020
13F
MARTINGALE ASSET MANAGEMENT L P
13F
Company
0.12%
125,211
$3,058,000 30 Jun 2020
13F
Swiss National Bank
13F
Company
0.11%
114,450
$2,795,000 30 Jun 2020
13F
SEI INVESTMENTS CO
13F
Company
0.1%
106,024
$2,590,000 30 Jun 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.1%
102,065
$2,492,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
0.09%
99,213
$2,422,000 30 Jun 2020
13F
HAP Trading, LLC
13F
Company
0.09%
96,480
$2,356,000 30 Jun 2020
13F
State of New Jersey Common Pension Fund D
13F
Company
0.09%
94,102
$2,298,000 30 Jun 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.09%
93,700
$2,288,000 30 Jun 2020
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.09%
92,609
$2,262,000 30 Jun 2020
13F
Tekla Capital Management LLC
13F
Company
0.08%
85,840
$2,096,000 30 Jun 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.08%
85,625
$2,091,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.07%
77,727
$1,898,000 30 Jun 2020
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.06%
67,102
$1,639,000 30 Jun 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.06%
65,839
$1,608,000 30 Jun 2020
13F
BESSEMER GROUP INC
13F
Company
0.06%
63,300
$1,546,000 30 Jun 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.06%
61,200
$1,495,000 30 Jun 2020
13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q3 2020

As of 30 Sep 2020, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 151 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,472,050 shares. The largest 10 holders included BlackRock Inc., JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, Essex Woodlands Management, Inc., VANGUARD GROUP INC, ArrowMark Colorado Holdings LLC, ALLIANCEBERNSTEIN L.P., FRANKLIN RESOURCES INC, JENNISON ASSOCIATES LLC, and Capital World Investors. This page lists 151 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
138
Q3 2020 holders
151
Holder diff
13
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.